| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0007 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.16 | 0.0007 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.0008 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |